Gina Novo Nordisk - Search News

Seeking Alpha · 21h

Novo Nordisk: Dips Like These Come Once Every Few Years

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy with promising growth in obesity care.

The Motley Fool on MSN · 17h

Why Novo Nordisk Stock Keeps Going Down

Novo Nordisk (NYSE: NVO) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, beginning with a 3% decline on Monday from last Friday's close, and falling another 2.

Investing.com on MSN · 1d

Bernstein raises Novo Nordisk stock target to DKK620

Bernstein analysts led by Florent Cespedes increased their price target on Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO) stock to DKK620.00, up from DKK600.00, while maintaining a Market Perform rating. The $365 billion market cap company,

Fierce Pharma1d

'We cannot stay silent': Novo Nordisk flags dangers of compounded GLP-1s following Hims & Hers Super Bowl ad

Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...

17h

NVO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Novo Nordisk A/S Stockholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

3d

The Physicians Really Are Healing Themselves, With Ozempic

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results